HEADER HYDROLASE 29-JAN-21 7LJK TITLE CRYSTAL STRUCTURE OF THE DEACYLATION DEFICIENT KPC-2 F72Y MUTANT COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-LACTAMASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.5.2.6; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: KLEBSIELLA PNEUMONIAE; SOURCE 3 ORGANISM_TAXID: 573; SOURCE 4 GENE: KPC-2, BLA, BLA_1, BLA_4, BLAKPC, BLAKPC-2, KPC2, B4U25_43300, SOURCE 5 BANRA_05566, C2U49_28140, C3F39_16210, C3F39_28515, C3F39_28975, SOURCE 6 C4Y50_021815, CK508_026140, DM059_13800, DM060_30440, DM078_27040, SOURCE 7 DN589_26110, EAO17_31575, FKC87_27985, GF489_24625, GS419_28405, SOURCE 8 IPF_358, KP64477D_00006, KPC_069, P628KPC_020, PCRE79_15, PCT- SOURCE 9 KPC_129, PFOS18_014, PKP469IL_0095, PKP53IL_00095, SOURCE 10 SAMEA3649709_04840, SAMEA3649772_05181, UC330_005, UC332_005, SOURCE 11 UC334_005; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KPC, CARBAPENEMASE, BETA-LACTAMASE, HYDROLASE, ANTIBIOTIC RESISTANCE, KEYWDS 2 ENZYME, BETA-LACTAM, ANTIBIOTICS EXPDTA X-RAY DIFFRACTION AUTHOR I.FUREY,T.PALZKILL,B.SANKARAN,L.HU,B.V.V.PRASAD REVDAT 6 16-OCT-24 7LJK 1 REMARK REVDAT 5 18-OCT-23 7LJK 1 REMARK REVDAT 4 21-JUL-21 7LJK 1 JRNL REVDAT 3 30-JUN-21 7LJK 1 AUTHOR REVDAT 2 02-JUN-21 7LJK 1 JRNL REVDAT 1 26-MAY-21 7LJK 0 JRNL AUTH I.M.FUREY,S.C.MEHTA,B.SANKARAN,L.HU,B.V.V.PRASAD,T.PALZKILL JRNL TITL LOCAL INTERACTIONS WITH THE GLU166 BASE AND THE CONFORMATION JRNL TITL 2 OF AN ACTIVE SITE LOOP PLAY KEY ROLES IN CARBAPENEM JRNL TITL 3 HYDROLYSIS BY THE KPC-2 BETA-LACTAMASE. JRNL REF J.BIOL.CHEM. V. 296 00799 2021 JRNL REFN ESSN 1083-351X JRNL PMID 34022225 JRNL DOI 10.1016/J.JBC.2021.100799 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.M.PAPP-WALLACE,N.Q.NGUYEN,M.R.JACOBS,C.R.BETHEL, REMARK 1 AUTH 2 M.D.BARNES,V.KUMAR,S.BAJAKSOUZIAN,S.D.RUDIN,P.N.RATHER, REMARK 1 AUTH 3 S.BHAVSAR,T.RAVIKUMAR,P.K.DESHPANDE,V.PATIL,R.YEOLE, REMARK 1 AUTH 4 S.S.BHAGWAT,M.V.PATEL,F.VAN DEN AKKER,R.A.BONOMO REMARK 1 TITL STRATEGIC APPROACHES TO OVERCOME RESISTANCE AGAINST REMARK 1 TITL 2 GRAM-NEGATIVE PATHOGENS USING BETA-LACTAMASE INHIBITORS AND REMARK 1 TITL 3 BETA-LACTAM ENHANCERS: ACTIVITY OF THREE NOVEL REMARK 1 TITL 4 DIAZABICYCLOOCTANES WCK 5153, ZIDEBACTAM (WCK 5107), AND WCK REMARK 1 TITL 5 4234. REMARK 1 REF J MED CHEM V. 61 4067 2018 REMARK 1 REFN ISSN 1520-4804 REMARK 1 PMID 29627985 REMARK 1 DOI 10.1021/ACS.JMEDCHEM.8B00091 REMARK 2 REMARK 2 RESOLUTION. 1.81 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3260 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.81 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.15 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.960 REMARK 3 COMPLETENESS FOR RANGE (%) : 88.9 REMARK 3 NUMBER OF REFLECTIONS : 32882 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.159 REMARK 3 R VALUE (WORKING SET) : 0.157 REMARK 3 FREE R VALUE : 0.197 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.860 REMARK 3 FREE R VALUE TEST SET COUNT : 1599 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 37.1500 - 4.0200 0.89 2807 196 0.1616 0.2103 REMARK 3 2 4.0200 - 3.1900 0.93 3010 148 0.1561 0.1678 REMARK 3 3 3.1900 - 2.7900 0.89 2822 143 0.1618 0.1930 REMARK 3 4 2.7900 - 2.5400 0.89 2851 122 0.1578 0.1947 REMARK 3 5 2.5400 - 2.3500 0.88 2835 140 0.1544 0.1796 REMARK 3 6 2.3500 - 2.2200 0.89 2878 126 0.1540 0.2307 REMARK 3 7 2.2200 - 2.1000 0.89 2872 131 0.1545 0.2150 REMARK 3 8 2.1000 - 2.0100 0.89 2854 143 0.1587 0.2098 REMARK 3 9 2.0100 - 1.9400 0.87 2795 142 0.1552 0.1888 REMARK 3 10 1.9400 - 1.8700 0.87 2770 153 0.1535 0.2000 REMARK 3 11 1.8700 - 1.8100 0.88 2789 155 0.1458 0.2041 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.147 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.423 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 6.99 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 10.75 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4018 REMARK 3 ANGLE : 0.903 5476 REMARK 3 CHIRALITY : 0.057 624 REMARK 3 PLANARITY : 0.007 714 REMARK 3 DIHEDRAL : 3.031 2390 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 16.5512 13.6165 8.9325 REMARK 3 T TENSOR REMARK 3 T11: 0.0025 T22: 0.0312 REMARK 3 T33: 0.0295 T12: 0.0106 REMARK 3 T13: 0.0219 T23: 0.0079 REMARK 3 L TENSOR REMARK 3 L11: 0.2652 L22: 0.3095 REMARK 3 L33: 0.3670 L12: 0.1421 REMARK 3 L13: 0.2471 L23: 0.1857 REMARK 3 S TENSOR REMARK 3 S11: 0.0003 S12: 0.0165 S13: 0.0028 REMARK 3 S21: 0.0267 S22: -0.0024 S23: 0.0081 REMARK 3 S31: -0.0092 S32: 0.0215 S33: -0.0017 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7LJK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-FEB-21. REMARK 100 THE DEPOSITION ID IS D_1000254441. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-SEP-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99999 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : POINTLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32888 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.810 REMARK 200 RESOLUTION RANGE LOW (A) : 37.150 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.9 REMARK 200 DATA REDUNDANCY : 1.800 REMARK 200 R MERGE (I) : 0.05725 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.8400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.81 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.88 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3C5A REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 33.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.85 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG 8,000, 0.1M KSCN, 0.1M SODIUM REMARK 280 ACETATE PH:4.5, PH 4.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 291 REMARK 465 GLY B 291 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU B 168 O HOH B 301 2.13 REMARK 500 O HOH A 308 O HOH A 372 2.19 REMARK 500 O HOH A 305 O HOH A 463 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 400 O HOH B 370 1544 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 69 -142.05 48.43 REMARK 500 ARG A 220 -120.70 -115.57 REMARK 500 CYS B 69 -140.18 49.37 REMARK 500 GLN B 87 82.56 -152.75 REMARK 500 TRP B 105 71.41 56.55 REMARK 500 ARG B 220 -120.22 -112.90 REMARK 500 REMARK 500 REMARK: NULL DBREF 7LJK A 26 291 UNP Q93LQ9 Q93LQ9_KLEPN 26 289 DBREF 7LJK B 26 291 UNP Q93LQ9 Q93LQ9_KLEPN 26 289 SEQADV 7LJK TYR A 72 UNP Q93LQ9 PHE 71 ENGINEERED MUTATION SEQADV 7LJK TYR B 72 UNP Q93LQ9 PHE 71 ENGINEERED MUTATION SEQRES 1 A 264 THR ASN LEU VAL ALA GLU PRO PHE ALA LYS LEU GLU GLN SEQRES 2 A 264 ASP PHE GLY GLY SER ILE GLY VAL TYR ALA MET ASP THR SEQRES 3 A 264 GLY SER GLY ALA THR VAL SER TYR ARG ALA GLU GLU ARG SEQRES 4 A 264 PHE PRO LEU CYS SER SER TYR LYS GLY PHE LEU ALA ALA SEQRES 5 A 264 ALA VAL LEU ALA ARG SER GLN GLN GLN ALA GLY LEU LEU SEQRES 6 A 264 ASP THR PRO ILE ARG TYR GLY LYS ASN ALA LEU VAL PRO SEQRES 7 A 264 TRP SER PRO ILE SER GLU LYS TYR LEU THR THR GLY MET SEQRES 8 A 264 THR VAL ALA GLU LEU SER ALA ALA ALA VAL GLN TYR SER SEQRES 9 A 264 ASP ASN ALA ALA ALA ASN LEU LEU LEU LYS GLU LEU GLY SEQRES 10 A 264 GLY PRO ALA GLY LEU THR ALA PHE MET ARG SER ILE GLY SEQRES 11 A 264 ASP THR THR PHE ARG LEU ASP ARG TRP GLU LEU GLU LEU SEQRES 12 A 264 ASN SER ALA ILE PRO GLY ASP ALA ARG ASP THR SER SER SEQRES 13 A 264 PRO ARG ALA VAL THR GLU SER LEU GLN LYS LEU THR LEU SEQRES 14 A 264 GLY SER ALA LEU ALA ALA PRO GLN ARG GLN GLN PHE VAL SEQRES 15 A 264 ASP TRP LEU LYS GLY ASN THR THR GLY ASN HIS ARG ILE SEQRES 16 A 264 ARG ALA ALA VAL PRO ALA ASP TRP ALA VAL GLY ASP LYS SEQRES 17 A 264 THR GLY THR CYS GLY VAL TYR GLY THR ALA ASN ASP TYR SEQRES 18 A 264 ALA VAL VAL TRP PRO THR GLY ARG ALA PRO ILE VAL LEU SEQRES 19 A 264 ALA VAL TYR THR ARG ALA PRO ASN LYS ASP ASP LYS HIS SEQRES 20 A 264 SER GLU ALA VAL ILE ALA ALA ALA ALA ARG LEU ALA LEU SEQRES 21 A 264 GLU GLY LEU GLY SEQRES 1 B 264 THR ASN LEU VAL ALA GLU PRO PHE ALA LYS LEU GLU GLN SEQRES 2 B 264 ASP PHE GLY GLY SER ILE GLY VAL TYR ALA MET ASP THR SEQRES 3 B 264 GLY SER GLY ALA THR VAL SER TYR ARG ALA GLU GLU ARG SEQRES 4 B 264 PHE PRO LEU CYS SER SER TYR LYS GLY PHE LEU ALA ALA SEQRES 5 B 264 ALA VAL LEU ALA ARG SER GLN GLN GLN ALA GLY LEU LEU SEQRES 6 B 264 ASP THR PRO ILE ARG TYR GLY LYS ASN ALA LEU VAL PRO SEQRES 7 B 264 TRP SER PRO ILE SER GLU LYS TYR LEU THR THR GLY MET SEQRES 8 B 264 THR VAL ALA GLU LEU SER ALA ALA ALA VAL GLN TYR SER SEQRES 9 B 264 ASP ASN ALA ALA ALA ASN LEU LEU LEU LYS GLU LEU GLY SEQRES 10 B 264 GLY PRO ALA GLY LEU THR ALA PHE MET ARG SER ILE GLY SEQRES 11 B 264 ASP THR THR PHE ARG LEU ASP ARG TRP GLU LEU GLU LEU SEQRES 12 B 264 ASN SER ALA ILE PRO GLY ASP ALA ARG ASP THR SER SER SEQRES 13 B 264 PRO ARG ALA VAL THR GLU SER LEU GLN LYS LEU THR LEU SEQRES 14 B 264 GLY SER ALA LEU ALA ALA PRO GLN ARG GLN GLN PHE VAL SEQRES 15 B 264 ASP TRP LEU LYS GLY ASN THR THR GLY ASN HIS ARG ILE SEQRES 16 B 264 ARG ALA ALA VAL PRO ALA ASP TRP ALA VAL GLY ASP LYS SEQRES 17 B 264 THR GLY THR CYS GLY VAL TYR GLY THR ALA ASN ASP TYR SEQRES 18 B 264 ALA VAL VAL TRP PRO THR GLY ARG ALA PRO ILE VAL LEU SEQRES 19 B 264 ALA VAL TYR THR ARG ALA PRO ASN LYS ASP ASP LYS HIS SEQRES 20 B 264 SER GLU ALA VAL ILE ALA ALA ALA ALA ARG LEU ALA LEU SEQRES 21 B 264 GLU GLY LEU GLY FORMUL 3 HOH *394(H2 O) HELIX 1 AA1 THR A 26 GLY A 41 1 16 HELIX 2 AA2 SER A 71 GLN A 87 1 17 HELIX 3 AA3 GLY A 89 ASP A 92 5 4 HELIX 4 AA4 GLY A 98 LEU A 102 5 5 HELIX 5 AA5 ILE A 108 LEU A 113 5 6 HELIX 6 AA6 VAL A 119 TYR A 129 1 11 HELIX 7 AA7 ASP A 131 LEU A 142 1 12 HELIX 8 AA8 GLY A 143 ILE A 155 1 13 HELIX 9 AA9 LEU A 167 SER A 171 5 5 HELIX 10 AB1 SER A 182 LEU A 195 1 14 HELIX 11 AB2 ALA A 200 GLY A 213 1 14 HELIX 12 AB3 ARG A 220 VAL A 225 5 6 HELIX 13 AB4 GLY A 239 GLY A 242 5 4 HELIX 14 AB5 SER A 275 LEU A 290 1 16 HELIX 15 AB6 ASN B 27 GLY B 41 1 15 HELIX 16 AB7 SER B 71 GLN B 87 1 17 HELIX 17 AB8 GLY B 89 ASP B 92 5 4 HELIX 18 AB9 GLY B 98 LEU B 102 5 5 HELIX 19 AC1 SER B 106 TYR B 112 1 7 HELIX 20 AC2 VAL B 119 SER B 130 1 12 HELIX 21 AC3 ASP B 131 LEU B 142 1 12 HELIX 22 AC4 GLY B 144 ILE B 155 1 12 HELIX 23 AC5 LEU B 167 SER B 171 5 5 HELIX 24 AC6 SER B 182 LEU B 195 1 14 HELIX 25 AC7 ALA B 200 GLY B 213 1 14 HELIX 26 AC8 ARG B 220 VAL B 225 5 6 HELIX 27 AC9 SER B 275 LEU B 290 1 16 SHEET 1 AA1 5 THR A 56 TYR A 60 0 SHEET 2 AA1 5 SER A 43 ASP A 50 -1 N VAL A 46 O TYR A 60 SHEET 3 AA1 5 ILE A 259 ARG A 266 -1 O VAL A 260 N MET A 49 SHEET 4 AA1 5 ALA A 244 TRP A 251 -1 N ASP A 246 O VAL A 263 SHEET 5 AA1 5 ALA A 230 THR A 237 -1 N GLY A 236 O ASN A 245 SHEET 1 AA2 2 PHE A 66 PRO A 67 0 SHEET 2 AA2 2 THR A 180 SER A 181 -1 O SER A 181 N PHE A 66 SHEET 1 AA3 2 PRO A 94 ILE A 95 0 SHEET 2 AA3 2 MET A 117 THR A 118 -1 O MET A 117 N ILE A 95 SHEET 1 AA4 5 THR B 56 TYR B 60 0 SHEET 2 AA4 5 SER B 43 ASP B 50 -1 N VAL B 46 O TYR B 60 SHEET 3 AA4 5 ILE B 259 ARG B 266 -1 O ARG B 266 N SER B 43 SHEET 4 AA4 5 ALA B 244 TRP B 251 -1 N VAL B 250 O ILE B 259 SHEET 5 AA4 5 ALA B 230 THR B 237 -1 N GLY B 236 O ASN B 245 SHEET 1 AA5 2 PHE B 66 PRO B 67 0 SHEET 2 AA5 2 THR B 180 SER B 181 -1 O SER B 181 N PHE B 66 SHEET 1 AA6 2 PRO B 94 ILE B 95 0 SHEET 2 AA6 2 MET B 117 THR B 118 -1 O MET B 117 N ILE B 95 SSBOND 1 CYS A 69 CYS A 238 1555 1555 2.08 SSBOND 2 CYS B 69 CYS B 238 1555 1555 2.06 CISPEP 1 GLU A 166 LEU A 167 0 5.47 CISPEP 2 GLU B 166 LEU B 167 0 6.26 CRYST1 34.325 37.310 82.178 92.43 90.41 94.62 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.029133 0.002353 0.000312 0.00000 SCALE2 0.000000 0.026890 0.001161 0.00000 SCALE3 0.000000 0.000000 0.012180 0.00000